greeksoup/ stock research

Dolby Laboratories (DLB) FY2021 results: revenue $1.3 billion, up 10.3% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $1.3 billion for fiscal 2021, the year ended 24 September 2021, up 10.3% on the year before. Net income was $310 million, up 34.1%, and diluted earnings per share $2.97. The figures are the company's own, from the 10-K it filed with the SEC on 17 November 2021.

Revenue
$1.3 billion
+10.3% on the year
FY2014FY2021
Operating margin
26.9%
18.8% a year earlier
FY2014FY2021
Net income
$310 million
+34.1% on the year
FY2014FY2021
Diluted EPS
$2.97
+32.0% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue1,2811,1621,242+10.3%
Cost of revenue130146161-11.2%
Gross profit1,1511,0151,081+13.4%
Gross margin89.9%87.4%87.0%
Research and development254239238+6.1%
Operating income344219257+57.4%
Operating margin26.9%18.8%20.7%
Interest expense0.50.20.2+157.5%
Pre-tax income355240282+47.9%
Income tax36.78.126.8+353.2%
Effective tax rate10.3%3.4%9.5%
Net income310231255+34.1%
Net margin24.2%19.9%20.5%
Diluted EPS$2.97$2.25$2.44+32.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow448344328+30.2%
Capital expenditure54.566.396.3-17.9%
Free cash flow393278231+41.7%
Free cash flow margin30.7%23.9%18.6%
Cash from investing-44.9134-56.2
Cash from financing-253-208-385
Depreciation and amortisation95.990.985.1+5.5%
Share-based compensation99.786.676.6+15.1%
Buybacks246174341+41.5%
Dividends paid89.288.677.5+0.7%
Dividend per share$0.91$0.88$0.79+3.4%
Diluted shares, weighted105m103m105m+1.6%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity2,5982,4332,307+6.8%
Non-controlling interest6.35.85.7+8.5%
Debt0.00.00.0
Operating lease liabilities56.765.30.0-13.2%
Other liabilities445414509+7.5%
Total liabilities and equity3,1062,9172,822+6.5%
Fixed assets534542537-1.4%
Goodwill341337335+1.1%
Intangible assets123152181-19.4%
Investments10299.1299+2.6%
Cash and equivalents1,2251,072797+14.3%
Receivables233180189+29.0%
Inventory11.025.632.3-57.1%
Other assets537509451+5.5%
Total assets3,1062,9172,822+6.5%

10-K for the year ended 24 September 2021, filed 17 November 2021: the filing.